IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
Parabolic Drugs IPO is a Book Building IPO listing on BSE,NSE exchange, with an ipo size of ₹ 200.00 Cr. The company is based in Chandigarh and caters to Pharmaceutical sector. Spa Capital Advisors , ICICI Securities are the merchant bankers of Parabolic Drugs IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 22nd January 2010.
Parabolic Drugs IPO open date is 14th June 2010 and close date is 17th June 2010. IPO Allotment Date is 30th November -0001 and Listing date is 1st July 2010.
IPO
Size:
₹ 200.00 Cr.
Avg IPO Size (Sector Based)
: ₹
1,431.30 cr.
Sector: Pharmaceutical
IPO so far:
23
Merchant Banker:
Spa Capital
IPO by BRLM so far:
2
City:
Chandigarh
IPO so far:
2
Revenue (annualised):
₹
466.86
cr. 
PE
Ratio:
12.93x
Average Sector PE Ratio: 27.10x
Parabolic Drugs IPO size is ₹ 200.00 Cr. with IPO price of ₹ 75.00. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Spa Capital Advisors Limited is the book-running lead manager of the Parabolic Drugs IPO. Link Intime India Private Limited is the Registrar for Parabolic Drugs IPO.
Parabolic Drugs IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Parabolic Drugs IPO, based in Chandigarh, operates in the Pharmaceutical sector with a focus on business of manufacturing Active Pharmaceutical Ingredients (API's) and API intermediates. The company is launching its MainBoard IPO on the BSE,NSE exchange, using the Book Building Issue method. Parabolic Drugs IPO size is ₹ 200.00 Cr. with fresh issue size of ₹ 200 Cr. and Offer for sale being ₹ Nil
The IPO allotment date for Parabolic Drugs IPO is expected to be 30th November -0001, after the finalization of basis of allotment. Investors can check Parabolic Drugs IPO allotment status on the registrars website, Link Intime India Private Limited . Parabolic Drugs IPO refund dates are 30th November -0001.
Parabolic Drugs IPO is expected to be listed on 1st July 2010.
The upper price band for the Parabolic Drugs IPO is set at ₹ 75.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Parabolic Drugs IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Parabolic Drugs IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 17th June 2010. After submission, funds are blocked until the basis of allotment of Parabolic Drugs IPO is finalised.
The merchant banker for Parabolic Drugs IPO is Spa Capital Advisors Limited , ICICI Securities Limited . Spa Capital Advisors Limited , ICICI Securities Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Parabolic Drugs IPO RHP for further details.
The registrar for Parabolic Drugs IPO is Link Intime India Private Limited . Investors can go to Link Intime India Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Parabolic Drugs IPO through their official website or helpline.
Parabolic Drugs IPO was subscribed 1.04 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
₹ 200.00 Cr.
Avg IPO Size (Sector Based)
:
₹ 1,431.30 Cr.
Sector: Pharmaceutical
IPO so far:
23
Merchant Banker:
Spa Capital
IPO by BRLM so far:
2
City:
Chandigarh
IPO so far:
2
Revenue (annualised):
₹ 464.70 cr.
PE
Ratio:
12.93x
Average Sector PE Ratio: 27.10x
Parabolic Drugs IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Parabolic Drugs Financial Review Page
Merchant Banker(s) of Parabolic Drugs IPO: Spa Capital Advisors Limited , ICICI Securities Limited
Parabolic Drugs IPO subscription was 1.04 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Parabolic Drugs IPO listed at a listing price of 64.80 against the offer price of 75.00.
The current market price of Parabolic Drugs is .
Why Us?
